Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab

Anne M. Schultheis, Georg Lurje, Katrin E. Rhodes, Wu Zhang, Dongyun Yang, Agustin A. Garcia, Robert Morgan, David R Gandara, Sidney A Scudder, Amit Oza, Hal Hirte, Gini Fleming, Lynda Roman, Heinz Josef Lenz

Research output: Contribution to journalArticlepeer-review

153 Scopus citations

Fingerprint

Dive into the research topics of 'Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab'. Together they form a unique fingerprint.

Medicine & Life Sciences